Client’s Testimonial:
“Thank you very much for your service, and I am glad that my I-140 was finally approved all these years.”
On October 27th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Graduate Research Assistant
Country of Origin: South Korea
State of Residence at the Time of Filing: Texas
Approval Notice Date: October 27th, 2025
Processing Time: 21 months, 3 days
Case Summary:
We are excited to share the success story of a biomedical scientist whose I-140 NIW (National Interest Waiver) petition was successfully approved. This achievement underscores the national value of advancing cancer research and the importance of supporting scientists who are driving innovation in disease prevention and treatment.
The client holds an M.S. in stem cell biology and is currently conducting research in biomedical science. The proposed endeavor focuses on characterizing the molecular mechanisms underlying human disease, particularly cancer recurrence, in order to accelerate the development of clinical tools and new therapeutic strategies. This work directly supports critical national priorities in improving cancer survival outcomes, reducing healthcare costs, and strengthening U.S. leadership in biotechnology and precision medicine.
Filed under the EB-2 NIW category, the petition highlighted:
-
5 peer-reviewed journal articles
-
2 first-authored conference abstracts and 1 first-authored preprint
-
A total of 76 citations from other researchers worldwide
-
Research funded by major U.S. biomedical research agencies and organizations (ACS, LLS, NIH, AHA, BCRF, V Foundation for Cancer Research)
The client’s research has already been applied in studies related to leukemia relapse, breast cancer therapy, and cardiac cell transplantation—demonstrating both clinical relevance and widespread influence within the scientific community. One project, for example, identified key leukemia stem cell properties linked to cancer recurrence and treatment resistance, offering promising opportunities for next-generation targeted therapies.
To further strengthen the case, two letters of recommendation from respected experts in biomedical research were submitted. These letters attested to the originality and real-world value of the client’s work, and emphasized the strong potential for ongoing contributions that benefit the United States.
“It is certainly within the best interests of the United States to continue to support and facilitate his endeavors.”
With a clear demonstration of national importance, a strong record of independent scientific influence, and the support of significant research funders, the petition successfully showed that waiving the labor certification requirement is in the best interest of the United States.
NAILG is honored to have assisted this talented scientist in securing approval and looks forward to seeing continued advancements in life-saving cancer research that will benefit both patients and the broader healthcare system.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation: https://www.wegreened.com/Free-Evaluation
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.